Back to Journals » ClinicoEconomics and Outcomes Research » Volume 5
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
14,763 | Dovepress* | 11,882+ | 2,626 | 14,508 | |
PubMed Central* | 2,881 | 1,054 | 3,935 | ||
Totals | 14,763 | 3,680 | 18,443 | ||
*Since 11 April 2013 +Since July 2016 |
View citations on PubMed and Google Scholar